HUNTINGTON BEACH, California — When patients of Aaron Mangold, MD, first learn they have mycosis fungoides (MF), the most common form of primary cutaneous T-cell lymphoma (CTCL), some are concerned ...
The RESMAIN trial by Rudolf Stadler and colleagues, published in The Lancet Haematology, showed that resminostat maintenance therapy significantly prolonged median progression-free survival (median ...
Once the diagnosis is established and the staging evaluation completed (see Table 1), therapy can be determined. Appropriate therapy depends upon a variety of factors, including stage (see Table 2), ...
Veterinary mycology encompasses the study of fungal pathogens in animals, addressing infections in companion animals, livestock, and wildlife. These infections range from superficial dermatomycoses to ...
(RTTNews) - Innate Pharma SA (IPHA) said that lacutamab, an anti-KIR3DL2 antibody, demonstrated clinical responses in patients with mycosis fungoides (MF), in the ongoing Phase 2 TELLOMAK clinical ...
The Journal of Clinical Oncology podcast, hosted by Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology.
Lacutamab is a first-in-class anti-KIR3DL2 humanized cytotoxicity-inducing antibody that is currently in clinical trials for treatment of cutaneous T-cell lymphoma (CTCL), an orphan disease, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results